+1 (646) 661-6066
query@marketresearchandstatistics.com
Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Global Molecular Diagnostics Market

$3600
  • Feb - 2017
  • In 
    • 1071 Views

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services.

Publisher’s Note: Reports from KBV Research comes with a powerful Market Research & Analytics tool which facilitates the client to see data graphically. Request a free demo of the Market Research & Analytics Tool here.
Report DescriptionResearch ScopeTable of ContentPricing

Global Molecular Diagnostics Market Overview

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

The key driving factors for molecular diagnostics market are high prevalence of infectious diseases and adoption of personalized medicines & companion diagnostics. Additionally, advanced diagnostics technologies and increase in the number of cancer diagnostics are some of the other factors leading the market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market.

Global Molecular Diagnostics Market Segmentation

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers.

Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Region, market is segmented into North America, Europe, Asia- Pacific and LAMEA (Latin America, Middle East and Africa). North America is expected to dominate the market growth owing to the increase in the number of infectious diseases. Unhealthy lifestyle and infectious diseases is becoming the major concern worldwide. According to the data estimated by Centers for Diseases Control and Prevention (CDC), number of deaths due to cancer estimated was 591,699 and Chronic lower respiratory diseases was 147,101. Additionally, According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. Hence, it could be expected that Asia Pacific and other regions would be contributing in the growth of molecular diagnostics market.

Global Molecular Diagnostics Market Key Companies

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report includeAbbott Laboratories,Qiagen N.V,Roche Diagnostics,Grifols,Siemens Healthcare (Siemens AG),Becton Dickinson and Company and Danaher Corporation.

Global Molecular Diagnostics Market Segmentation

Market Segmentation:

By Product & Services

  • Reagents & Kits
  • Instruments
  • Software& Services

By Technology

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
  • Microarray
  • Other Technologies

By Application

  • Infectious Diseases
    • Chlamydia Trachomatis & Neisseria Gonorrhoea
    • Hepatitis B & Hepatitis C
    • Human Papillomavirus
    • Human Immunodeficiency Virus
    • Tuberculosis
    • Methicillin-Resistant Staphylococcus Aurous
    • Others
  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Other Cancers
  • Blood Screening
  • Genetic Tests
  • Microbiology
  • Other Applications

By End User

  • Hospital & Academic Laboratories
  • Reference Laboratories
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia-Pacific
  • Latin America, Middle East and Africa (LAMEA)
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Company Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage of Molecular Diagnostics Market
  • Highest number of market tables
  • Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
  • Subscription based model available
  • Free of cost quarterly updates
  • Free of cost automatic pdf report generation
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Chapter 1.  Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  Global Molecular Diagnostics Market, by Product & Services

1.4.2  Global Molecular Diagnostics Market, by Technology

1.4.3  Global Molecular Diagnostics Market, by Application

1.4.4  Global Molecular Diagnostics Market, by End User

1.4.5  Global Molecular Diagnostics Market, by Geography

1.5  Methodology for the research

Chapter 2.  Executive Summary

Chapter 3.  Market Overview

3.1  Introduction

3.2  Drivers, Restraints and Opportunities

3.2.1  Market Drivers

3.2.2  Market Restraints

Chapter 4.  Global Molecular Diagnostics Market

4.1  Global Molecular Diagnostics Market by Product & Services

4.1.1  Global Molecular Diagnostics Reagents & Kits Market by Region

4.1.2  Global Molecular Diagnostics Instruments Market by Region

4.1.3  Global Molecular Diagnostics Software & Services Market by Region

Chapter 5.  Global Molecular Diagnostics Market by Technology

5.1  Introduction

5.1.1  Global Polymerase Chain Reaction Molecular Diagnostics Market by Region

5.1.2  Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Region

5.1.3  Global Hybridization Molecular Diagnostics Market by Region

5.1.4  Global DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Region

5.1.5  Global Microarray Molecular Diagnostics Market by Region

5.1.6  Global Other Technologies Market by Region

Chapter 6.  Global Molecular Diagnostics Market by Application

6.1  Introduction

6.1.1  Global Infectious Diseases Molecular Diagnostics Market by Region

6.1.2  Global Infectious Diseases Molecular Diagnostics Market by Type

6.1.2.1  Global Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Region

6.1.2.2  Global Hepatitis B & Hepatitis C Molecular Diagnostics Market by Region

6.1.2.3  Global Human Papillomavirus Molecular Diagnostics Market by Region

6.1.2.4  Global Human Immunodeficiency Virus Molecular Diagnostics Market by Region

6.1.2.5  Global Tuberculosis Molecular Diagnostics Market by Region

6.1.2.6  Global Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Region

6.1.2.7  Global Molecular Diagnostics in Other Infectious Diseases Market by Region

6.1.3  Global Oncology Molecular Diagnostics Market by Region

6.1.4  Global Oncology Molecular Diagnostics Market by Type

6.1.4.1  Global Breast Cancer Molecular Diagnostics Market by Region

6.1.4.2  Global Colorectal Cancer Molecular Diagnostics Market by Region

6.1.4.3  Global Prostate Cancer Molecular Diagnostics Market by Region

6.1.4.4  Global Other Cancers Molecular Diagnostics Market by Region

6.1.5  Global Blood Screening Molecular Diagnostics Market by Region

6.1.6  Global Genetic Tests Molecular Diagnostics Market by Region

6.1.7  Global Microbiology Molecular Diagnostics Market by Region

6.1.8  Global Other Applications Market by Region

Chapter 7.  Global Molecular Diagnostics Market by End User

7.1  Introduction

7.1.1  Global Molecular Diagnostics Market for Hospital & Academic Laboratories by Region

7.1.2  Global Molecular Diagnostics Market for Reference Laboratories by Region

7.1.3  Global Molecular Diagnostics Market for Other End Users by Region

Chapter 8.  Global Molecular Diagnostics Market by Region

8.1  Introduction

8.2  North America Molecular Diagnostics Market

8.2.1  North America Molecular Diagnostics Market by Product & Services

8.2.1.1  North America Molecular Diagnostics Reagents & Kits Market by Country

8.2.1.2  North America Molecular Diagnostics Instruments Market by Country

8.2.1.3  North America Molecular Diagnostics Software & Services Market by Country

8.2.2  North America Molecular Diagnostics Market by Technology

8.2.2.1  North America Polymerase Chain Reaction Molecular Diagnostics Market by Country

8.2.2.2  North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

8.2.2.3  North America Hybridization Molecular Diagnostics Market by Country

8.2.2.4  North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

8.2.2.5  North America Microarray Molecular Diagnostics Market by Country

8.2.2.6  North America Other Technologies Market by Country

8.2.3  North America Molecular Diagnostics Market by Application

8.2.3.1  North America Infectious Diseases Molecular Diagnostics Market by Country

8.2.3.2  North America Infectious Diseases Molecular Diagnostics Market by Type

8.2.3.2.1  North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

8.2.3.2.2  North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

8.2.3.2.3  North America Human Papillomavirus Molecular Diagnostics Market by Country

8.2.3.2.4  North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country

8.2.3.2.5  North America Tuberculosis Molecular Diagnostics Market by Country

8.2.3.2.6  North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

8.2.3.2.7  North America Molecular Diagnostics in Other Infectious Diseases Market by Country

8.2.3.3  North America Oncology Molecular Diagnostics Market by Country

8.2.3.4  North America Oncology Molecular Diagnostics Market by Type

8.2.3.4.1  North America Breast Cancer Molecular Diagnostics Market by Country

8.2.3.4.2  North America Colorectal Cancer Molecular Diagnostics Market by Country

8.2.3.4.3  North America Prostate Cancer Molecular Diagnostics Market by Country

8.2.3.4.4  North America Other Cancers Molecular Diagnostics Market by Country

8.2.3.5  North America Blood Screening Molecular Diagnostics Market by Country

8.2.3.6  North America Genetic Tests Molecular Diagnostics Market by Country

8.2.3.7  North America Microbiology Molecular Diagnostics Market by Country

8.2.3.8  North America Other Applications Market by Country

8.2.4  North America Molecular Diagnostics Market by End User

8.2.4.1  North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

8.2.4.2  North America Molecular Diagnostics Market for Reference Laboratories by Country

8.2.4.3  North America Molecular Diagnostics Market for Other End Users by Country

8.2.5  North America Molecular Diagnostics Market by Country

8.2.5.1  US Molecular Diagnostics Market

8.2.5.1.1  US Molecular Diagnostics Market by Product & Services

8.2.5.1.2  US Molecular Diagnostics Market by Technology

8.2.5.1.3  US Molecular Diagnostics Market by Application

8.2.5.1.4  US Molecular Diagnostics Market by End User

8.2.5.2  Canada Molecular Diagnostics Market

8.2.5.2.1  Canada Molecular Diagnostics Market by Product & Services

8.2.5.2.2  Canada Molecular Diagnostics Market by Technology

8.2.5.2.3  Canada Molecular Diagnostics Market by Application

8.2.5.2.4  Canada Molecular Diagnostics Market by End User

8.2.5.3  Mexico Molecular Diagnostics Market

8.2.5.3.1  Mexico Molecular Diagnostics Market by Product & Services

8.2.5.3.2  Mexico Molecular Diagnostics Market by Technology

8.2.5.3.3  Mexico Molecular Diagnostics Market by Application

8.2.5.3.4  Mexico Molecular Diagnostics Market by End User

8.2.5.4  Rest of North America Molecular Diagnostics Market

8.2.5.4.1  Rest of North America Molecular Diagnostics Market by Product & Services

8.2.5.4.2  Rest of North America Molecular Diagnostics Market by Technology

8.2.5.4.3  Rest of North America Molecular Diagnostics Market by Application

8.2.5.4.4  Rest of North America Molecular Diagnostics Market by End User

8.3  Europe Molecular Diagnostics Market

8.3.1  Europe Molecular Diagnostics Market by Product & Services

8.3.1.1  Europe Molecular Diagnostics Reagents & Kits Market by Country

8.3.1.2  Europe Molecular Diagnostics Instruments Market by Country

8.3.1.3  Europe Molecular Diagnostics Software & Services Market by Country

8.3.2  Europe Molecular Diagnostics Market by Technology

8.3.2.1  Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country

8.3.2.2  Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

8.3.2.3  Europe Hybridization Molecular Diagnostics Market by Country

8.3.2.4  Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

8.3.2.5  Europe Microarray Molecular Diagnostics Market by Country

8.3.2.6  Europe Other Technologies Market by Country

8.3.3  Europe Molecular Diagnostics Market by Application

8.3.3.1  Europe Infectious Diseases Molecular Diagnostics Market by Country

8.3.3.2  Europe Infectious Diseases Molecular Diagnostics Market by Type

8.3.3.2.1  Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

8.3.3.2.2  Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

8.3.3.2.3  Europe Human Papillomavirus Molecular Diagnostics Market by Country

8.3.3.2.4  Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country

8.3.3.2.5  Europe Tuberculosis Molecular Diagnostics Market by Country

8.3.3.2.6  Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

8.3.3.2.7  Europe Molecular Diagnostics in Other Infectious Diseases Market by Country

8.3.3.3  Europe Oncology Molecular Diagnostics Market by Country

8.3.3.4  Europe Oncology Molecular Diagnostics Market by Type

8.3.3.4.1  Europe Breast Cancer Molecular Diagnostics Market by Country

8.3.3.4.2  Europe Colorectal Cancer Molecular Diagnostics Market by Country

8.3.3.4.3  Europe Prostate Cancer Molecular Diagnostics Market by Country

8.3.3.4.4  Europe Other Cancers Molecular Diagnostics Market by Country

8.3.3.5  Europe Blood Screening Molecular Diagnostics Market by Country

8.3.3.6  Europe Genetic Tests Molecular Diagnostics Market by Country

8.3.3.7  Europe Microbiology Molecular Diagnostics Market by Country

8.3.3.8  Europe Other Applications Market by Country

8.3.4  Europe Molecular Diagnostics Market by End User

8.3.4.1  Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

8.3.4.2  Europe Molecular Diagnostics Market for Reference Laboratories by Country

8.3.4.3  Europe Molecular Diagnostics Market for Other End Users by Country

8.3.5  Europe Molecular Diagnostics Market by Country

8.3.5.1  Germany Molecular Diagnostics Market

8.3.5.1.1  Germany Molecular Diagnostics Market by Product & Services

8.3.5.1.2  Germany Molecular Diagnostics Market by Technology

8.3.5.1.3  Germany Molecular Diagnostics Market by Application

8.3.5.1.4  Germany Molecular Diagnostics Market by End User

8.3.5.2  UK Molecular Diagnostics Market

8.3.5.2.1  UK Molecular Diagnostics Market by Product & Services

8.3.5.2.2  UK Molecular Diagnostics Market by Technology

8.3.5.2.3  UK Molecular Diagnostics Market by Application

8.3.5.2.4  UK Molecular Diagnostics Market by End User

8.3.5.3  France Molecular Diagnostics Market

8.3.5.3.1  France Molecular Diagnostics Market by Product & Services

8.3.5.3.2  France Molecular Diagnostics Market by Technology

8.3.5.3.3  France Molecular Diagnostics Market by Application

8.3.5.3.4  France Molecular Diagnostics Market by End User

8.3.5.4  Russia Molecular Diagnostics Market

8.3.5.4.1  Russia Molecular Diagnostics Market by Product & Services

8.3.5.4.2  Russia Molecular Diagnostics Market by Technology

8.3.5.4.3  Russia Molecular Diagnostics Market by Application

8.3.5.4.4  Russia Molecular Diagnostics Market by End User

8.3.5.5  Spain Molecular Diagnostics Market

8.3.5.5.1  Spain Molecular Diagnostics Market by Product & Services

8.3.5.5.2  Spain Molecular Diagnostics Market by Technology

8.3.5.5.3  Spain Molecular Diagnostics Market by Application

8.3.5.5.4  Spain Molecular Diagnostics Market by End User

8.3.5.6  Italy Molecular Diagnostics Market

8.3.5.6.1  Italy Molecular Diagnostics Market by Product & Services

8.3.5.6.2  Italy Molecular Diagnostics Market by Technology

8.3.5.6.3  Italy Molecular Diagnostics Market by Application

8.3.5.6.4  Italy Molecular Diagnostics Market by End User

8.3.5.7  Rest of Europe Molecular Diagnostics Market

8.3.5.7.1  Rest of Europe Molecular Diagnostics Market by Product & Services

8.3.5.7.2  Rest of Europe Molecular Diagnostics Market by Technology

8.3.5.7.3  Rest of Europe Molecular Diagnostics Market by Application

8.3.5.7.4  Rest of Europe Molecular Diagnostics Market by End User

8.4  Asia-Pacific Molecular Diagnostics Market

8.4.1  Asia-Pacific Molecular Diagnostics Market by Product & Services

8.4.1.1  Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country

8.4.1.2  Asia-Pacific Molecular Diagnostics Instruments Market by Country

8.4.1.3  Asia-Pacific Molecular Diagnostics Software & Services Market by Country

8.4.2  Asia-Pacific Molecular Diagnostics Market by Technology

8.4.2.1  Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country

8.4.2.2  Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

8.4.2.3  Asia-Pacific Hybridization Molecular Diagnostics Market by Country

8.4.2.4  Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

8.4.2.5  Asia-Pacific Microarray Molecular Diagnostics Market by Country

8.4.2.6  Asia-Pacific Other Technologies Market by Country

8.4.3  Asia-Pacific Molecular Diagnostics Market by Application

8.4.3.1  Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country

8.4.3.2  Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type

8.4.3.2.1  Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

8.4.3.2.2  Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

8.4.3.2.3  Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country

8.4.3.2.4  Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country

8.4.3.2.5  Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country

8.4.3.2.6  Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

8.4.3.2.7  Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country

8.4.3.3  Asia-Pacific Oncology Molecular Diagnostics Market by Country

8.4.3.4  Asia-Pacific Oncology Molecular Diagnostics Market by Type

8.4.3.4.1  Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country

8.4.3.4.2  Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country

8.4.3.4.3  Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country

8.4.3.4.4  Asia-Pacific Other Cancers Molecular Diagnostics Market by Country

8.4.3.5  Asia-Pacific Blood Screening Molecular Diagnostics Market by Country

8.4.3.6  Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country

8.4.3.7  Asia-Pacific Microbiology Molecular Diagnostics Market by Country

8.4.3.8  Asia-Pacific Other Applications Market by Country

8.4.4  Asia-Pacific Molecular Diagnostics Market by End User

8.4.4.1  Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

8.4.4.2  Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country

8.4.4.3  Asia-Pacific Molecular Diagnostics Market for Other End Users by Country

8.4.5  Asia-Pacific Molecular Diagnostics Market by Country

8.4.5.1  China Molecular Diagnostics Market

8.4.5.1.1  China Molecular Diagnostics Market by Product & Services

8.4.5.1.2  China Molecular Diagnostics Market by Technology

8.4.5.1.3  China Molecular Diagnostics Market by Application

8.4.5.1.4  China Molecular Diagnostics Market by End User

8.4.5.2  Japan Molecular Diagnostics Market

8.4.5.2.1  Japan Molecular Diagnostics Market by Product & Services

8.4.5.2.2  Japan Molecular Diagnostics Market by Technology

8.4.5.2.3  Japan Molecular Diagnostics Market by Application

8.4.5.2.4  Japan Molecular Diagnostics Market by End User

8.4.5.3  India Molecular Diagnostics Market

8.4.5.3.1  India Molecular Diagnostics Market by Product & Services

8.4.5.3.2  India Molecular Diagnostics Market by Technology

8.4.5.3.3  India Molecular Diagnostics Market by Application

8.4.5.3.4  India Molecular Diagnostics Market by End User

8.4.5.4  South Korea Molecular Diagnostics Market

8.4.5.4.1  South Korea Molecular Diagnostics Market by Product & Services

8.4.5.4.2  South Korea Molecular Diagnostics Market by Technology

8.4.5.4.3  South Korea Molecular Diagnostics Market by Application

8.4.5.4.4  South Korea Molecular Diagnostics Market by End User

8.4.5.5  Australia Molecular Diagnostics Market

8.4.5.5.1  Australia Molecular Diagnostics Market by Product & Services

8.4.5.5.2  Australia Molecular Diagnostics Market by Technology

8.4.5.5.3  Australia Molecular Diagnostics Market by Application

8.4.5.5.4  Australia Molecular Diagnostics Market by End User

8.4.5.6  Singapore Molecular Diagnostics Market

8.4.5.6.1  Singapore Molecular Diagnostics Market by Product & Services

8.4.5.6.2  Singapore Molecular Diagnostics Market by Technology

8.4.5.6.3  Singapore Molecular Diagnostics Market by Application

8.4.5.6.4  Singapore Molecular Diagnostics Market by End User

8.4.5.7  Rest of Asia-Pacific Molecular Diagnostics Market

8.4.5.7.1  Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services

8.4.5.7.2  Rest of Asia-Pacific Molecular Diagnostics Market by Technology

8.4.5.7.3  Rest of Asia-Pacific Molecular Diagnostics Market by Application

8.4.5.7.4  Rest of Asia-Pacific Molecular Diagnostics Market by End User

8.5  LAMEA Molecular Diagnostics Market

8.5.1  LAMEA Molecular Diagnostics Market by Product & Services

8.5.1.1  LAMEA Molecular Diagnostics Reagents & Kits Market by Country

8.5.1.2  LAMEA Molecular Diagnostics Instruments Market by Country

8.5.1.3  LAMEA Molecular Diagnostics Software & Services Market by Country

8.5.2  LAMEA Molecular Diagnostics Market by Technology

8.5.2.1  LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country

8.5.2.2  LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

8.5.2.3  LAMEA Hybridization Molecular Diagnostics Market by Country

8.5.2.4  LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

8.5.2.5  LAMEA Microarray Molecular Diagnostics Market by Country

8.5.2.6  LAMEA Other Technologies Market by Country

8.5.3  LAMEA Molecular Diagnostics Market by Application

8.5.3.1  LAMEA Infectious Diseases Molecular Diagnostics Market by Country

8.5.3.2  LAMEA Infectious Diseases Molecular Diagnostics Market by Type

8.5.3.2.1  LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

8.5.3.2.2  LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

8.5.3.2.3  LAMEA Human Papillomavirus Molecular Diagnostics Market by Country

8.5.3.2.4  LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country

8.5.3.2.5  LAMEA Tuberculosis Molecular Diagnostics Market by Country

8.5.3.2.6  LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

8.5.3.2.7  LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country

8.5.3.3  LAMEA Oncology Molecular Diagnostics Market by Country

8.5.3.4  LAMEA Oncology Molecular Diagnostics Market by Type

8.5.3.4.1  LAMEA Breast Cancer Molecular Diagnostics Market by Country

8.5.3.4.2  LAMEA Colorectal Cancer Molecular Diagnostics Market by Country

8.5.3.4.3  LAMEA Prostate Cancer Molecular Diagnostics Market by Country

8.5.3.4.4  LAMEA Other Cancers Molecular Diagnostics Market by Country

8.5.3.5  LAMEA Blood Screening Molecular Diagnostics Market by Country

8.5.3.6  LAMEA Genetic Tests Molecular Diagnostics Market by Country

8.5.3.7  LAMEA Microbiology Molecular Diagnostics Market by Country

8.5.3.8  LAMEA Other Applications Market by Country

8.5.4  LAMEA Molecular Diagnostics Market by End User

8.5.4.1  LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

8.5.4.2  LAMEA Molecular Diagnostics Market for Reference Laboratories by Country

8.5.4.3  LAMEA Molecular Diagnostics Market for Other End Users by Country

8.5.5  LAMEA Molecular Diagnostics Market by Country

8.5.5.1  Brazil Molecular Diagnostics Market

8.5.5.1.1  Brazil Molecular Diagnostics Market by Product & Services

8.5.5.1.2  Brazil Molecular Diagnostics Market by Technology

8.5.5.1.3  Brazil Molecular Diagnostics Market by Application

8.5.5.1.4  Brazil Molecular Diagnostics Market by End User

8.5.5.2  Argentina Molecular Diagnostics Market

8.5.5.2.1  Argentina Molecular Diagnostics Market by Product & Services

8.5.5.2.2  Argentina Molecular Diagnostics Market by Technology

8.5.5.2.3  Argentina Molecular Diagnostics Market by Application

8.5.5.2.4  Argentina Molecular Diagnostics Market by End User

8.5.5.3  UAE Molecular Diagnostics Market

8.5.5.3.1  UAE Molecular Diagnostics Market by Product & Services

8.5.5.3.2  UAE Molecular Diagnostics Market by Technology

8.5.5.3.3  UAE Molecular Diagnostics Market by Application

8.5.5.3.4  UAE Molecular Diagnostics Market by End User

8.5.5.4  Saudi Arabia Molecular Diagnostics Market

8.5.5.4.1  Saudi Arabia Molecular Diagnostics Market by Product & Services

8.5.5.4.2  Saudi Arabia Molecular Diagnostics Market by Technology

8.5.5.4.3  Saudi Arabia Molecular Diagnostics Market by Application

8.5.5.4.4  Saudi Arabia Molecular Diagnostics Market by End User

8.5.5.5  South Africa Molecular Diagnostics Market

8.5.5.5.1  South Africa Molecular Diagnostics Market by Product & Services

8.5.5.5.2  South Africa Molecular Diagnostics Market by Technology

8.5.5.5.3  South Africa Molecular Diagnostics Market by Application

8.5.5.5.4  South Africa Molecular Diagnostics Market by End User

8.5.5.6  Nigeria Molecular Diagnostics Market

8.5.5.6.1  Nigeria Molecular Diagnostics Market by Product & Services

8.5.5.6.2  Nigeria Molecular Diagnostics Market by Technology

8.5.5.6.3  Nigeria Molecular Diagnostics Market by Application

8.5.5.6.4  Nigeria Molecular Diagnostics Market by End User

8.5.5.7  Rest of LAMEA Molecular Diagnostics Market

8.5.5.7.1  Rest of LAMEA Molecular Diagnostics Market by Product & Services

8.5.5.7.2  Rest of LAMEA Molecular Diagnostics Market by Technology

8.5.5.7.3  Rest of LAMEA Molecular Diagnostics Market by Application

8.5.5.7.4  Rest of LAMEA Molecular Diagnostics Market by End User

Chapter 9.  Company Profiles

9.1  Abbott Laboratories

9.1.1  Company Overview

9.1.2  Financial Analysis

9.1.3  Segmental and Regional Analysis

9.1.4  Research & Development Expense

9.2  Qiagen N.V.

9.2.1  Company Overview

9.2.2  Financial Analysis

9.2.3  Segmental and Regional Analysis

9.2.4  Research & Development Expense

9.3  Roche Diagnostics

9.3.1  Company Overview

9.3.2  Financial Analysis

9.3.3  Segmental and Regional Analysis

9.3.4  Research & Development Expense

9.4  Grifols

9.4.1  Company Overview

9.4.2  Financial Analysis

9.4.3  Segmental and Regional Analysis

9.5  Siemens Healthcare (Siemens AG)

9.5.1  Company Overview

9.5.2  Financial Analysis

9.5.3  Segmental and Regional Analysis

9.5.4  Research & Development Expense

9.6  Becton Dickinson and Company

9.6.1  Company Overview

9.6.2  Financial Analysis

9.6.3  Segmental and Regional Analysis

9.6.4  Research & Development Expense

9.7  Danaher Corporation

9.7.1  Company Overview

9.7.2  Financial Analysis

9.7.3  Segmental and Regional Analysis

9.7.4  Research & Development Expense

LIST OF TABLES

TABLE 1  GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 2  GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 3  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 4  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 5  GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 6  GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 7  GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 8  GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 9  GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 10  GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 11  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 12  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 13  GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 14  GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 15  GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 16  GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 17  GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 18  GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 19  GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 20  GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 21  GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 22  GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 23  GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 24  GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 25  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 26  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 27  GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 28  GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 29  GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 30  GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 31  GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 32  GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 33  GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 34  GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 35  GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 36  GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 37  GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 38  GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 39  GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 40  GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 41  GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 42  GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 43  GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 44  GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 45  GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 46  GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 47  GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 48  GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 49  GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 50  GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 51  GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 52  GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 53  GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 54  GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 55  GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 56  GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 57  GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 58  GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 59  GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 60  GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 61  GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 62  GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 63  GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 64  GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 65  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 66  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 67  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2012 – 2015, USD MILLION

TABLE 68  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2016 – 2022, USD MILLION

TABLE 69  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2012 – 2015, USD MILLION

TABLE 70  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2016 – 2022, USD MILLION

TABLE 71  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2012 – 2015, USD MILLION

TABLE 72  GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2016 – 2022, USD MILLION

TABLE 73  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 – 2015, USD MILLION

TABLE 74  GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 – 2022, USD MILLION

TABLE 75  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 76  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 77  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 78  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 79  NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 80  NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 81  NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 82  NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 83  NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 84  NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 85  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 86  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 87  NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 88  NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 89  NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 90  NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 91  NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 92  NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 93  NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 94  NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 95  NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 96  NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 97  NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 98  NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 99  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 100  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 101  NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 102  NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 103  NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 104  NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 105  NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 106  NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 107  NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 108  NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 109  NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 110  NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 111  NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 112  NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 113  NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 114  NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 115  NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 116  NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 117  NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 118  NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 119  NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 120  NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 121  NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 122  NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 123  NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 124  NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 125  NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 126  NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 127  NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 128  NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 129  NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 130  NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 131  NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 132  NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 133  NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 134  NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 135  NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 136  NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 137  NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 138  NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 139  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 140  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 141  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 142  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 143  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 144  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 145  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 146  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 147  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 148  NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 149  US MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 150  US MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 151  US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 152  US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 153  US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 154  US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 155  US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 156  US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 157  US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 158  US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 159  US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 160  US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 161  US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 162  US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 163  CANADA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 164  CANADA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 165  CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 166  CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 167  CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 168  CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 169  CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 170  CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 171  CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 172  CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 173  CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 174  CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 175  CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 176  CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 177  MEXICO MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 178  MEXICO MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 179  MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 180  MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 181  MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 182  MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 183  MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 184  MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 185  MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 186  MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 187  MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 188  MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 189  MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 190  MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 191  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 192  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 193  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 194  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 195  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 196  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 197  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 198  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 199  REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 200  REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 201  REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 202  REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 203  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 204  REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 205  EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 206  EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 207  EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 208  EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 209  EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 210  EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 211  EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 212  EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 213  EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 214  EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 215  EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 216  EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 217  EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 218  EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 219  EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 220  EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 221  EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 222  EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 223  EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 224  EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 225  EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 226  EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 227  EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 228  EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 229  EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 230  EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 231  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 232  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 233  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 234  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 235  EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 236  EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 237  EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 238  EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 239  EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 240  EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 241  EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 242  EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 243  EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 244  EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 245  EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 246  EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 247  EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 248  EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 249  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 250  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 251  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 252  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 253  EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 254  EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 255  EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 256  EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 257  EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 258  EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 259  EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 260  EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 261  EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 262  EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 263  EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 264  EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 265  EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 266  EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 267  EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 268  EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 269  EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 270  EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 271  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 272  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 273  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 274  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 275  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 276  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 277  EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 278  EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 279  GERMANY MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 280  GERMANY MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 281  GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 282  GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 283  GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 284  GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 285  GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 286  GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 287  GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 288  GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 289  GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 290  GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 291  GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 292  GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 293  UK MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 294  UK MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 295  UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 296  UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 297  UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 298  UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 299  UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 300  UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 301  UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 302  UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 303  UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 304  UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 305  UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 306  UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 307  FRANCE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 308  FRANCE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 309  FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 310  FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 311  FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 312  FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 313  FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 314  FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 315  FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 316  FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 317  FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 318  FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 319  FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 320  FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 321  RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 322  RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 323  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 324  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 325  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 326  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 327  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 328  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 329  RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 330  RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 331  RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 332  RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 333  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 334  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 335  SPAIN MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 336  SPAIN MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 337  SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 338  SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 339  SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 340  SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 341  SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 342  SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 343  SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 344  SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 345  SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 346  SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 347  SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 348  SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 349  ITALY MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 350  ITALY MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 351  ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 352  ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 353  ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 354  ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 355  ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 356  ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 357  ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 358  ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 359  ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 360  ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 361  ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 362  ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 363  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 364  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 365  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 366  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 367  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 368  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 369  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 370  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 371  REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 372  REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 373  REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 374  REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 375  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 376  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 377  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 378  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 379  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 380  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 381  ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 382  ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 383  ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 384  ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 385  ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 386  ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 387  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 388  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 389  ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 390  ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 391  ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 392  ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 393  ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 394  ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 395  ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 396  ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 397  ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 398  ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 399  ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 400  ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 401  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 402  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 403  ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 404  ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 405  ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 406  ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 407  ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 408  ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 409  ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 410  ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 411  ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 412  ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 413  ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 414  ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 415  ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 416  ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 417  ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 418  ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 419  ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 420  ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 421  ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 422  ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 423  ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 424  ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 425  ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 426  ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 427  ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 428  ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 429  ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 430  ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 431  ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 432  ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 433  ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 434  ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 435  ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 436  ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 437  ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 438  ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 439  ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 440  ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 441  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 442  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 443  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 444  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 445  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 446  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 447  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 448  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 449  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 450  ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 451  CHINA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 452  CHINA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 453  CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 454  CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 455  CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 456  CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 457  CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 458  CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 459  CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 460  CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 461  CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 462  CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 463  CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 464  CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 465  JAPAN MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 466  JAPAN MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 467  JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 468  JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 469  JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 470  JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 471  JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 472  JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 473  JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 474  JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 475  JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 476  JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 477  JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 478  JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 479  INDIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 480  INDIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 481  INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 482  INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 483  INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 484  INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 485  INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 486  INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 487  INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 488  INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 489  INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 490  INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 491  INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 492  INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 493  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 494  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 495  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 496  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 497  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 498  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 499  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 500  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 501  SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 502  SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 503  SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 504  SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 505  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 506  SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 507  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 508  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 509  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 510  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 511  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 512  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 513  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 514  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 515  AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 516  AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 517  AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 518  AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 519  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 520  AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 521  SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 522  SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 523  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 524  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 525  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 526  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 527  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 528  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 529  SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 530  SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 531  SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 532  SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 533  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 534  SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 535  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 536  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 537  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 538  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 539  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 540  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 541  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 542  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 543  REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 544  REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 545  REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 546  REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 547  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 548  REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 549  LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 550  LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 551  LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 552  LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 553  LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 554  LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 555  LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 556  LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 557  LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 558  LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 559  LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 560  LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 561  LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 562  LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 563  LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 564  LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 565  LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 566  LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 567  LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 568  LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 569  LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 570  LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 571  LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 572  LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 573  LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 574  LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 575  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 576  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 577  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 578  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 579  LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 580  LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 581  LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 582  LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 583  LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 584  LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 585  LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 586  LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 587  LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 588  LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 589  LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 590  LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 591  LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 592  LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 593  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 594  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 595  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 596  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 597  LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 598  LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 599  LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 600  LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 601  LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 602  LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 603  LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 604  LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 605  LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 606  LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 607  LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 608  LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 609  LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 610  LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 611  LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 612  LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 613  LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 614  LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 615  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 616  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 617  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 618  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 619  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 620  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 621  LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 622  LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 623  BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 624  BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 625  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 626  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 627  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 628  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 629  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 630  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 631  BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 632  BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 633  BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 634  BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 635  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 636  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 637  ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 638  ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 639  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 640  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 641  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 642  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 643  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 644  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 645  ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 646  ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 647  ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 648  ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 649  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 650  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 651  UAE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 652  UAE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 653  UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 654  UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 655  UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 656  UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 657  UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 658  UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 659  UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 660  UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 661  UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 662  UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 663  UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 664  UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 665  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 666  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 667  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 668  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 669  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 670  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 671  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 672  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 673  SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 674  SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 675  SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 676  SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 677  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 678  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 679  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 680  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 681  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 682  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 683  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 684  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 685  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 686  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 687  SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 688  SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 689  SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 690  SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 691  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 692  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 693  NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 694  NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 695  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 696  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 697  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 698  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 699  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 700  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 701  NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 702  NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 703  NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 704  NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 705  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 706  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 707  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 708  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 709  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 710  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 711  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 712  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 713  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 714  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 715  REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 716  REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 717  REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 718  REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 719  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 720  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 721  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 722  KEY INFORMATION – QUIAGEN N.V.

TABLE 723  KEY INFORMATION – ROCHE DIAGNOSTIC

TABLE 724  KEY INFORMATION – GRIFOLS

TABLE 725  KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)

TABLE 726  KEY INFORMATION – BECTON DICKINSON AND COMPANY

TABLE 727  KEY INFORMATION – DANAHER CORPORATION


LICENSE TYPE



Subscribe

Subscribe us for latest industry updates.

Enter your company email below:

    Email

    New Customer?

    Request for discount

    Click Here!

    Have Questions?

    We are available 24x7

    Contact Us!

    Why MRAS?

    Extensive range of reports

    Excellent post-sale services

    Selective publisher base

    Best Pricing

    Quick Links

    > About Us
    > Solutions
    > Privacy Policy
    > Refund Policy

    Connect with Us:

    Address

    244 Fifth Avenue, Suite 1407, New York, N.Y. 10001 United States (U.S)
    +1 (646) 661-6066
    info@marketresearchandstatistics.com

    Business Hours

    The support team is available 24x7 to assist you.

    Working Days - Monday to Friday Working Hours - 10:00 AM to 7:00 PM

    Payment Methods

    Secured with

    © 2024 Market Research and Statistics. All Right Reserved.